共 56 条
[1]
Torre LA(2012)(2015) Global cancer statistics CA Cancer J Clin 65 87-108
[2]
Bray F(2015)Epidemiology of hepatocellular carcinoma Surg Oncol Clin N Am 24 1-17
[3]
Siegel RL(2010)Hepatocellular carcinoma: occurence, risk factors, biomarkers Orvosi Hetilap 151 933-940
[4]
Lafaro KJ(2008)Design and endpoints of clinical trials in hepatocellular carcinoma J Natl Cancer Inst 100 698-711
[5]
Demirjian AN(2008)Contrast-enhanced ultrasound for the characterization of focal liver lesions–diagnostic accuracy in clinical practice (DEGUM multicenter trial) Ultraschall Med 29 499-505
[6]
Pawlik TM(2013)Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver–update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM FLAUS and ICUS. Ultraschall Med 34 11-29
[7]
Fehér J(2011)Management of hepatocellular carcinoma: an update Hepatology 53 1020-1022
[8]
Lengyel G(2016)Factors affecting the enhancement patterns of intrahepatic cholangiocarcinoma (ICC) on contrast-enhanced ultrasound (CEUS) and their pathological correlations in patients with a single lesion Ultraschall Med 37 609-618
[9]
Llovet JM(2018)Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules J Hepatol 68 485-492
[10]
Di Bisceglie AM(2018)Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis Bguidance Hepatology 67 1560-1599